Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Molecular Cancer Research|2014Cited by 80
2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitorsAbran Costales, Cynthia M. Shafer, Anne B. Jefferson et al.|Bioorganic & Medicinal Chemistry Letters|2014Cited by 28
Supplementary Figures 1 - 4 from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0
Supplementary Methods from Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven CancersIda Aronchik, Anne B. Jefferson, B.A. Appleton et al.|Unknown|2023Cited by 0